Patent · US Active

Peptides and methods for the treatment of diabetes

US11760782B2 · kind B2 · utility

0Cited by

7References

11Claims

0Family size

Assignee

IMCYSE SA · BE

Inventors

Luc Vander Elst · Obaix, BE
Vincent Carlier · Énines, BE
Jean-Marie Saint-Remy · Grez-Doiceau, BE

Key dates

Filing date	Jun 30, 2022
Grant date	Sep 19, 2023
Priority date	—
Expiry date	Jun 30, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/577
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to peptides such as HCPYCSLQPLALEGSLQKRG [SEQ ID NO: 26] and their use in the treatment of type 1 diabetes and the generation of cytolytic CD4+ T cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.